---
title: "YONGDONG's application for the private placement of shares has been approved for registration by the China Securities Regulatory Commission"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262320145.md"
description: "According to the Zhitong Finance APP, YONGDONG announced that the company recently received the \"Approval on Shanxi Yongdong Chemical Co., Ltd. to Issue Stocks to Specific Objects\" issued by the China Securities Regulatory Commission, agreeing to the company's application for stock issuance registration to specific objects"
datetime: "2025-10-23T00:22:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262320145.md)
  - [en](https://longbridge.com/en/news/262320145.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262320145.md)
---

# YONGDONG's application for the private placement of shares has been approved for registration by the China Securities Regulatory Commission

According to the Zhitong Finance APP, YONGDONG (002753.SZ) announced that the company recently received the "Approval on the Registration of Shanxi YONGDONG Chemical Co., Ltd. to Issue Stocks to Specific Objects" issued by the China Securities Regulatory Commission, agreeing to the company's registration application for issuing stocks to specific objects

### Related Stocks

- [002753.CN](https://longbridge.com/en/quote/002753.CN.md)

## Related News & Research

- [Exploring Three Undiscovered Gems in the Middle East Market](https://longbridge.com/en/news/286881831.md)
- [The Gulf needs carbon taxes, not just capture, to reach net zero](https://longbridge.com/en/news/287138239.md)
- [International Energy Agency Is Wrong To Forecast Coal's Demise](https://longbridge.com/en/news/286899857.md)
- [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md)
- [Extended hold might be enough to contain inflation, BOE’s Taylor says](https://longbridge.com/en/news/287233334.md)